<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="caffey" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">caffey</book-part-id>
      <title-group>
        <title>Caffey Disease</title>
        <alt-title alt-title-type="alt-title">Synonym: Infantile Cortical Hyperostosis</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Guerin</surname>
            <given-names>Andrea</given-names>
          </name>
          <degrees>BSc, MD</degrees>
          <aff>Division of Clinical and Metabolic Genetics<break/>Department of Paediatrics<break/>The Hospital for Sick Children and University of Toronto<break/>Toronto, Canada</aff>
          <email>andrea.guerin@sickkids.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dupuis</surname>
            <given-names>Lucie</given-names>
          </name>
          <degrees>MS, MSc, CGC</degrees>
          <aff>Division of Clinical and Metabolic Genetics<break/>Department of Paediatrics<break/>The Hospital for Sick Children and University of Toronto<break/>Toronto, Canada</aff>
          <email>lucie.dupuis@sickkids.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mendoza-Londono</surname>
            <given-names>Roberto</given-names>
          </name>
          <degrees>MD, MS, FACMG, FCCMG</degrees>
          <aff>Division of Clinical and Metabolic Genetics<break/>Department of Paediatrics<break/>The Hospital for Sick Children and University of Toronto<break/>Toronto, Canada</aff>
          <email>roberto.mendoza@sickkids.ca</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2012-08-02" date-type="created">
          <day>2</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date iso-8601-date="2012-11-29" date-type="revised">
          <day>29</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="col4a1-dis" document-type="chapter">
<italic toggle="yes">COL4A1</italic>-Related Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="lgmd2a" document-type="chapter">Calpainopathy</related-object>
      <abstract id="caffey.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Caffey disease is characterized by massive subperiosteal new bone formation (usually involving the diaphyses of the long bones as well as the ribs, mandible, scapulae, and clavicles) typically associated with fever, joint swelling, and pain in children, with onset around age two months and spontaneous resolution by age two years. On rare occasion, the hyperostosis can be detected by ultrasound examination late in the third trimester of pregnancy. Limited follow-up information suggests that adults who had Caffey disease in childhood may manifest joint laxity, skin hyperextensibility, hernias, and an increased risk for bone fractures and/or deformities.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Radiologic findings of subperiosteal cortical hyperostosis of the diaphyses of the long bones (with sparing of the epiphyses), ribs, scapulae, clavicles, and mandible in a child age two months to five years suggest the diagnosis. The <italic toggle="yes">COL1A1</italic> variant c.3040C&#x0003e;T (p.Arg1014Cys; also known as p.Arg836Cys) in exon 41 is the defining pathogenic variant currently identified in all individuals with Caffey disease undergoing molecular genetic testing. Although allelic and/or locus heterogeneity are possible, neither has been observed to date.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Anti-inflammatory agents, antipyretics, and analgesics can be used in the short term to decrease swelling and fever and to relieve pain.</p>
          <p><italic toggle="yes">Surveillance:</italic> Currently, no standard surveillance protocols exist; however, yearly evaluation of linear growth, dental health, joint range of motion re extensibility, possible hernias, and fracture history is recommended.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Caffey disease is inherited in an autosomal dominant manner. Some individuals diagnosed with Caffey disease have a parent who had Caffey disease in childhood; others have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown. Each child of an individual who had Caffey disease in childhood has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in the family has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="caffey.Diagnosis">
        <title>Diagnosis</title>
        <p>Diagnosis of Caffey disease is based on the following [<xref ref-type="bibr" rid="caffey.REF.lachman.2007">Lachman 2007</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>Clinical findings of irritability, fever, and/or pallor accompanied by soft tissue swelling adjacent to involved bones</p>
          </list-item>
          <list-item>
            <p>Radiologic findings of subperiosteal cortical hyperostosis of the diaphyses of the long bones (with sparing of the epiphyses), as well as the ribs, scapulae, clavicles, and mandible. Hyperostosis typically appears between birth and age five months and resolves spontaneously by age two years.</p>
          </list-item>
          <list-item>
            <p>Presence of the defining <italic toggle="yes">COL1A1</italic> pathogenic variant <xref ref-type="table" rid="caffey.T.selected_col1a1_pathogenic_vari">c.3040C&#x0003e;T</xref> (p.Arg1014Cys) (also known as p.Arg836Cys)</p>
          </list-item>
        </list>
        <p>See <xref ref-type="fig" rid="caffey.F1">Figure 1</xref>, and <xref ref-type="fig" rid="caffey.F2">Figure 2</xref>.</p>
        <sec id="caffey.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">COL1A1</italic> is the only gene in which a pathogenic variant is known to cause Caffey disease. The <italic toggle="yes">COL1A1</italic>
<xref ref-type="table" rid="caffey.T.selected_col1a1_pathogenic_vari">c.3040C&#x0003e;T</xref> (p.Arg1014Cys; also known as p.Arg836Cys) variant in exon 41 is currently the defining pathogenic variant involved in Caffey disease. See <xref ref-type="table" rid="caffey.T.summary_of_molecular_genetic_te">Table 1</xref>.</p>
          <p><bold>Evidence for locus heterogeneity.</bold> All probands identified to date come to clinical attention due to episodes of cortical hyperostosis. All published cases in which molecular testing has been done involve heterozygosity for the single known <xref ref-type="table" rid="caffey.T.selected_col1a1_pathogenic_vari">c.3040C&#x0003e;T</xref> pathogenic variant. However, one patient who meets clinical criteria does not have this variant, suggesting allelic or genetic heterogeneity [Author, unpublished observation].</p>
          <table-wrap id="caffey.T.summary_of_molecular_genetic_te" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Caffey Disease</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">COL1A1</italic>
                  </td>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants / sequence analysis of exon 41<hr/></td>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="table" rid="caffey.T.selected_col1a1_pathogenic_vari">c.3040C&#x0003e;T</xref>
                    <hr/>
                  </td>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">100% for c.3040C&#x0003e;T targeted variant<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>4</sup><hr/></td>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants throughout the coding and splicing regions&#x000a0;<sup>5</sup><hr/></td>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown, none reported to date&#x000a0;<sup>5</sup><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Partial- and whole-gene deletions/duplications&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_caffey.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown, none reported to date&#x000a0;<sup>5</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="caffey.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="caffey" object-id="caffey.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="caffey.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="caffey.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="caffey.TF.1.3">
                <label>3. </label>
                <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
              </fn>
              <fn id="caffey.TF.1.4">
                <label>4. </label>
                <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="caffey.TF.1.5">
                <label>5. </label>
                <p>The clinical utility of sequencing the gene or deletion/duplication analysis is unknown. The yield is expected to be very low as no such variants have been reported as causative of Caffey disease.</p>
              </fn>
              <fn id="caffey.TF.1.6">
                <label>6. </label>
                <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="caffey.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in an infant or young child</bold> in whom clinical findings suggest the diagnosis of Caffey disease:</p>
          <list list-type="bullet">
            <list-item>
              <p>Perform a skeletal survey for evidence of cortical hyperostosis in the long bones, clavicles, ribs mandible, and any other areas that clinically appear to be swollen.</p>
            </list-item>
            <list-item>
              <p>If hyperostosis is found, perform molecular genetic testing for the defining <italic toggle="yes">COL1A1</italic> c.3040C&#x0003e;T (p.Arg1014Cys; also known as p.Arg836Cys) pathogenic variant. Note: At this time, there is no role for either sequence analysis of the <italic toggle="yes">COL1A1</italic> coding region or duplication/deletion analysis.</p>
            </list-item>
          </list>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family<italic toggle="yes">.</italic></p>
        </sec>
      </sec>
      <sec id="caffey.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="caffey.Clinical_Description">
          <title>Clinical Description</title>
          <p>Caffey disease is characterized by massive subperiosteal new bone formation usually involving the diaphyses of the long bones, as well as the ribs, mandible, scapulae, and clavicles [<xref ref-type="bibr" rid="caffey.REF.caffey.1945.1">Caffey &#x00026; Silverman 1945</xref>, <xref ref-type="bibr" rid="caffey.REF.caffey.1957.347">Caffey 1957</xref>]. Typically the skeletal manifestations of Caffey disease first appear with fever, joint swelling and pain between birth and age five months, and resolve before age two years [<xref ref-type="bibr" rid="caffey.REF.kamoungoldrat.2008.2145">Kamoun-Goldrat &#x00026; le Merrer 2008</xref>, <xref ref-type="bibr" rid="caffey.REF.cerrutimainardi.2011.1385">Cerruti-Mainardi et al 2011</xref>, <xref ref-type="bibr" rid="caffey.REF.ranganath.2011.877">Ranganath et al 2011</xref>]. The clinical findings most often appear at age two months.</p>
          <p>On rare occasion, the hyperostosis can be detected by ultrasound examination late in the third trimester of pregnancy [<xref ref-type="bibr" rid="caffey.REF.schweiger.2003.547">Schweiger et al 2003</xref>]. One report describes prenatal periosteal inflammation in a fetus heterozygous for the defining <italic toggle="yes">COL1A1</italic> pathogenic variant [<xref ref-type="bibr" rid="caffey.REF.kamoungoldrat.2008.1820">Kamoun-Goldrat et al 2008</xref>].</p>
          <p>Although episodes of recurrence of hyperostosis have been reported on occasion [<xref ref-type="bibr" rid="caffey.REF.thometz.1996.304">Thometz &#x00026; DiRaimondo 1996</xref>], the likelihood of a recurrence is unknown, as are the contributing factors.</p>
          <p>In a family described by <xref ref-type="bibr" rid="caffey.REF.gensure.2005.1250">Gensure et al [2005]</xref>, an individual with the defining <italic toggle="yes">COL1A1</italic> pathogenic variant had a history of Caffey disease as a child, and joint laxity and skin hyperextensibility with a history of hernias and multiple fractures in adulthood. Subsequent clinical examination of other individuals in that family who also had the defining <italic toggle="yes">COL1A1</italic> pathogenic variant revealed varying degrees of joint laxity and hyperextensibility. Skin biopsy of affected individuals showed collagen fibrils that were larger, more variable in shape, and less densely packed than age- and sex-matched controls. Granulofilamentous material was also visible in the matrix along the collagen fibrils. Cultured fibroblasts showed a mix of normal type I collagen and abnormal disulfide crosslinking, either within or between mutated collagen fibrils. The findings reported by <xref ref-type="bibr" rid="caffey.REF.gensure.2005.1250">Gensure et al [2005]</xref> have not been found in other families with the same pathogenic variant [<xref ref-type="bibr" rid="caffey.REF.cho.2008.947">Cho et al 2008</xref>, <xref ref-type="bibr" rid="caffey.REF.cerrutimainardi.2011.1385">Cerruti-Mainardi et al 2011</xref>, <xref ref-type="bibr" rid="caffey.REF.ranganath.2011.877">Ranganath et al 2011</xref>]</p>
          <p>Although anecdotal evidence suggests that the manifestations of Caffey disease resolve spontaneously by age two years and do not predispose to long-term bone abnormalities, the literature on Caffey disease does not directly address long-term outcomes. The study of a single family suggested that individuals who have the defining pathogenic variant may be prone to short stature and residual bone deformities [<xref ref-type="bibr" rid="caffey.REF.suphapeetiporn.2007.280">Suphapeetiporn et al 2007</xref>]. In addition, it has been suggested that fractures (possibly related to decreased bone mineral density) may be more common in these individuals [<xref ref-type="bibr" rid="caffey.REF.gensure.2005.1250">Gensure et al 2005</xref>, <xref ref-type="bibr" rid="caffey.REF.suphapeetiporn.2007.280">Suphapeetiporn et al 2007</xref>].</p>
          <p>Other bone-related complications may potentially occur: in one case report a child with Caffey disease developed tumoral calcinosis (thought to be due to constant remodeling) after repeated inflammatory events [<xref ref-type="bibr" rid="caffey.REF.issa_el_khoury.2012.286">Issa El Khoury et al 2012</xref>].</p>
          <p>Observed laboratory findings in a few affected individuals:</p>
          <list list-type="bullet">
            <list-item>
              <p>Serum biochemical markers of inflammation (white blood cell count, erythrocyte sedimentation rate, C-reactive protein) have been elevated [<xref ref-type="bibr" rid="caffey.REF.gensure.2005.1250">Gensure et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Anemia and thrombocytosis have been described in single case reports [<xref ref-type="bibr" rid="caffey.REF.restrepo.2004.454">Restrepo et al 2004</xref>, <xref ref-type="bibr" rid="caffey.REF.krishnamurthy.2012.345">Krishnamurthy &#x00026; Srinivasan 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Bone and muscle biopsy of affected sites in a few patients have demonstrated an inflammatory reaction [<xref ref-type="bibr" rid="caffey.REF.katz.1981.77">Katz et al 1981</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="caffey.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Within the range of <italic toggle="yes">COL1A1</italic> pathogenic variants responsible for different phenotypes, the <italic toggle="yes">COL1A1</italic>
<xref ref-type="table" rid="caffey.T.selected_col1a1_pathogenic_vari">c.3040C&#x0003e;T</xref> variant is the defining variant responsible for the Caffey disease phenotype. See <xref ref-type="sec" rid="caffey.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
        </sec>
        <sec id="caffey.Penetrance">
          <title>Penetrance</title>
          <p>Incomplete penetrance based on family history or molecular genetic testing has been noted [<xref ref-type="bibr" rid="caffey.REF.newberg.1981.93">Newberg &#x00026; Tampas 1981</xref>, <xref ref-type="bibr" rid="caffey.REF.cho.2008.947">Cho et al 2008</xref>]. In a family studied by <xref ref-type="bibr" rid="caffey.REF.gensure.2005.1250">Gensure et al [2005]</xref>, 19 of 24 (79%) individuals with the defining <italic toggle="yes">COL1A1</italic> pathogenic variant had a clinical history of an episode consistent with Caffey disease.</p>
        </sec>
        <sec id="caffey.Nomenclature">
          <title>Nomenclature</title>
          <p>&#x0201c;Prenatal lethal forms of hyperostosis,&#x0201d; also referred to as &#x0201c;prenatal Caffey disease&#x0201d; or &#x0201c;Caffey dysplasia&#x0201d; [<xref ref-type="bibr" rid="caffey.REF.nemec.2012.e565">Nemec et al 2012</xref>], are distinct from Caffey disease (also known as infantile cortical hyperostosis) (see <xref ref-type="sec" rid="caffey.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
        </sec>
        <sec id="caffey.Prevalence">
          <title>Prevalence</title>
          <p>The number of clinical reports of Caffey disease described to date is no more than a few hundred; however, given the spontaneous resolution of this condition in early childhood, it is likely underdiagnosed.</p>
          <p>The defining <italic toggle="yes">COL1A1</italic> p.Arg1014Cys (also known as p.Arg836Cys) pathogenic variant does not appear to be more prevalent in one particular ethnic group. It has been described in white [<xref ref-type="bibr" rid="caffey.REF.gensure.2005.1250">Gensure et al 2005</xref>, <xref ref-type="bibr" rid="caffey.REF.cerrutimainardi.2011.1385">Cerruti-Mainardi et al 2011</xref>], Indian [<xref ref-type="bibr" rid="caffey.REF.ranganath.2011.877">Ranganath et al 2011</xref>], Thai [<xref ref-type="bibr" rid="caffey.REF.suphapeetiporn.2007.280">Suphapeetiporn et al 2007</xref>], Korean [<xref ref-type="bibr" rid="caffey.REF.cho.2008.947">Cho et al 2008</xref>], and Japanese individuals [<xref ref-type="bibr" rid="caffey.REF.hasegawa.2004.175">Hasegawa et al 2004</xref>].</p>
        </sec>
      </sec>
      <sec id="caffey.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>The following phenotypes are known to be associated with pathogenic variants in <italic toggle="yes">COL1A1</italic>:</p>
        <list list-type="bullet">
          <list-item>
            <p>
              <related-object link-type="booklink" source-id="gene" document-id="oi" document-type="chapter">Osteogenesis imperfecta</related-object>
            </p>
          </list-item>
          <list-item>
            <p>Ehlers-Danlos syndrome, arthrochalasia type (EDS VII)</p>
          </list-item>
          <list-item>
            <p>Rarely, an Ehlers-Danlos syndrome phenotype that resembles the <related-object link-type="booklink" source-id="gene" document-id="eds" document-type="chapter">classic type</related-object>. The arginine-to-cysteine amino acid substitution, Arg134Cys, in the &#x003b1;1(I) chain of type I collagen has been reported in individuals with classic Ehlers-Danlos syndrome [<xref ref-type="bibr" rid="caffey.REF.nuytinck.2000.1398">Nuytinck et al 2000</xref>].</p>
          </list-item>
          <list-item>
            <p>The association of three arginine-to-cysteine changes (Arg134Cys, Arg915Cys, and Arg396Cys) reported in an Ehlers Danlos syndrome phenotype with a propensity to arterial rupture in early adulthood [<xref ref-type="bibr" rid="caffey.REF.malfait.2007.387">Malfait et al 2007</xref>]</p>
          </list-item>
        </list>
      </sec>
      <sec id="caffey.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other conditions may manifest as joint swelling and hyperostosis and thus need to be distinguished from Caffey disease:</p>
        <list list-type="bullet">
          <list-item>
            <p>Lethal prenatal Caffey disease (prenatal Caffey disease/Caffey dysplasia). This condition typically presents before 35 weeks&#x02019; gestation and is characterized by corticial hyperostosis as well as bowing or angulation of the long bones and the presence of polyhydramnious and fetal lung disease [<xref ref-type="bibr" rid="caffey.REF.langer.1986.377">Langer &#x00026; Kaufmann 1986</xref>, <xref ref-type="bibr" rid="caffey.REF.l_colier.1992.637">L&#x000e9;colier et al 1992</xref>, <xref ref-type="bibr" rid="caffey.REF.drinkwater.1997.773">Drinkwater et al 1997</xref>, <xref ref-type="bibr" rid="caffey.REF.dahlstrom.2001.521">Dahlstrom et al 2001</xref>, <xref ref-type="bibr" rid="caffey.REF.savarirayan.2002.694">Savarirayan et al 2002</xref>, <xref ref-type="bibr" rid="caffey.REF.hall.2005">Hall 2005</xref>, <xref ref-type="bibr" rid="caffey.REF.hochwald.2011.113">Hochwald &#x00026; Osiovich 2011</xref>, <xref ref-type="bibr" rid="caffey.REF.nemec.2012.e565">Nemec et al 2012</xref>]. Autosomal recessive inheritance involving genes other than <italic toggle="yes">COL1A1</italic> has been proposed [<xref ref-type="bibr" rid="caffey.REF.de_jong.1995.134">de Jong &#x00026; Muller 1995</xref>, <xref ref-type="bibr" rid="caffey.REF.drinkwater.1997.773">Drinkwater et al 1997</xref>, <xref ref-type="bibr" rid="caffey.REF.schweiger.2003.547">Schweiger et al 2003</xref>, <xref ref-type="bibr" rid="caffey.REF.gensure.2005.1250">Gensure et al 2005</xref>].</p>
          </list-item>
          <list-item>
            <p>Non-accidental childhood injury (child physical abuse/non-accidental trauma). The prevalence of physical abuse is much greater than the prevalence of Caffey disease. Often the clinical history and presence of fractures, which are not usually a presenting feature of Caffey disease, aid in distinguishing the two conditions [<xref ref-type="bibr" rid="caffey.REF.al_kaissi.2009.133">Al Kaissi et al 2009</xref>, <xref ref-type="bibr" rid="caffey.REF.lo.2010.397">Lo et al 2010</xref>].</p>
          </list-item>
          <list-item>
            <p>Hypervitaminosis A, which can result in bone pain and swelling, similar to that seen in Caffey disease. In addition, hyperostosis has been documented in adults with hypervitaminosis A [<xref ref-type="bibr" rid="caffey.REF.wendling.2009.409">Wendling et al 2009</xref>].</p>
          </list-item>
          <list-item>
            <p>Prostaglandin E<sub>1</sub> (PGE1) exposure. Reversible hyperostosis and long bone swelling has been noted in neonates on PGE1 therapy for several weeks for maintenance of ductus arteriosus patency in the context of congenital heart disease [<xref ref-type="bibr" rid="caffey.REF.de_almeida.2007.363">de Almeida et al 2007</xref>].</p>
          </list-item>
          <list-item>
            <p>Hyperphosphatemia-hyperostosis syndrome (HHS). A rare disorder caused by pathogenic variants in <italic toggle="yes">GALNT3,</italic> HHS is characterized by hyperphosphatemia, normal or elevated 1,25-dihydroxyvitamin D(3) concentrations, and cortical hyperostosis [<xref ref-type="bibr" rid="caffey.REF.olauson.2008.929">Olauson et al 2008</xref>].</p>
          </list-item>
          <list-item>
            <p>Storage diseases presenting in early infancy (including I-cell disease (<related-object link-type="booklink" source-id="gene" document-id="ml2" document-type="chapter">mucolipidosis type II</related-object>) and <related-object link-type="booklink" source-id="gene" document-id="gm1-ganglio" document-type="chapter">GM1 gangliosidosis</related-object> type I), which may be characterized by periosteal cloaking; however, the involvement of the metaphysis and generalized findings of these conditions differentiate them from Caffey disease [<xref ref-type="bibr" rid="caffey.REF.hall.2005">Hall 2005</xref>].</p>
          </list-item>
          <list-item>
            <p>Bone malignancies, which may also be suspected initially; biopsies have been performed in the past to rule out this diagnosis [<xref ref-type="bibr" rid="caffey.REF.katz.1981.77">Katz et al 1981</xref>].</p>
          </list-item>
          <list-item>
            <p>Osteomyelitis, which may be mistakenly diagnosed as joint swelling. Febrile episodes can be common to both conditions; however, the finding of hyperostosis on x-ray helps distinguish between these two entities [<xref ref-type="bibr" rid="caffey.REF.behbehani.1997">Behbehani et al 1997</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="caffey.Management">
        <title>Management</title>
        <sec id="caffey.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with Caffey disease, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation for joint range of motion, tissue hyperlaxity, and hernias</p>
            </list-item>
            <list-item>
              <p>Radiographs of long bones, ribs, scapulae, clavicles, and mandible to assess extent of disease and the stage of hyperostosis</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="caffey.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Anti-inflammatory agents, antipyretics, and analgesics can be used in the short term to decrease swelling and fever and to relieve pain [<xref ref-type="bibr" rid="caffey.REF.thometz.1996.304">Thometz &#x00026; DiRaimondo 1996</xref>, <xref ref-type="bibr" rid="caffey.REF.parnell.2010.s39">Parnell &#x00026; Parisi 2010</xref>].</p>
          <p>Although immunoglobulins have also been tried [<xref ref-type="bibr" rid="caffey.REF.berthier.1988.443">Berthier et al 1988</xref>], no definitive treatment guidelines exist.</p>
          <p>No recommendations for the prevention of recurrence of hyperostosis currently exist.</p>
        </sec>
        <sec id="caffey.Surveillance">
          <title>Surveillance</title>
          <p>Currently, no standard surveillance protocols exist. However, given that Caffey disease is a collagenopathy, yearly evaluation of stature, joint extensibility, hernias, fracture history, and dental health is recommended.</p>
          <p>Although no systematic reviews of bone mineral density in adults with the defining pathogenic variant have been performed, reports of fractures and short stature in adults with other <italic toggle="yes">COL1A1</italic> pathogenic variants suggest that assessment of bone mineral density may be prudent in adults with a history of Caffey disease in childhood.</p>
        </sec>
        <sec id="caffey.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="caffey.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="caffey.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>No special recommendations for management of either a fetus known to be heterozygous for the disease-defining pathogenic variant or a mother known to have had Caffey disease in childhood.</p>
        </sec>
        <sec id="caffey.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="caffey.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="caffey.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Caffey disease is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="caffey.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with Caffey disease have a parent who had Caffey disease in childhood [<xref ref-type="bibr" rid="caffey.REF.tampas.1961.491">Tampas et al 1961</xref>, <xref ref-type="bibr" rid="caffey.REF.bull.1974.139">Bull &#x00026; Feingold 1974</xref>, <xref ref-type="bibr" rid="caffey.REF.fried.1981.271">Fried et al 1981</xref>, <xref ref-type="bibr" rid="caffey.REF.newberg.1981.93">Newberg &#x00026; Tampas 1981</xref>].</p>
            </list-item>
            <list-item>
              <p>A proband with Caffey disease may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of the parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular testing for the known variant and detailed medical history focusing on symptoms of hyperostosis in infancy and current bone health. Therefore, an apparently negative family history cannot be confirmed until molecular testing for the known pathogenic variant has been performed.Note: Although some individuals diagnosed with Caffey disease have a parent who had Caffey disease in childhood, the family history may appear to be negative because of failure to recognize or remember the occurrence of the disorder in family members or because of reduced penetrance in a parent [<xref ref-type="bibr" rid="caffey.REF.fried.1981.271">Fried et al 1981</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband had Caffey disease in childhood, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents did not have Caffey disease, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for Caffey disease because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual who had Caffey disease in childhood has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents. If a parent had Caffey disease, his or her family members may be at risk.</p>
        </sec>
        <sec id="caffey.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant</bold>. When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who were affected as children.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="caffey.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the <italic toggle="yes">COL1A1</italic> pathogenic variant has been identified in an affected family member, prenatal diagnosis and preimplantation genetic diagnosis for a pregnancy at increased risk for Caffey disease are possible options.</p>
          <p>Requests for prenatal testing for conditions which (like Caffey disease) do not affect intellect and have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although decisions about prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Ultrasound evaluation.</bold> A diagnosis of the typical infantile form of Caffey disease presenting with hyperostosis was made on the basis of ultrasound examination after 35 weeks&#x02019; gestation [<xref ref-type="bibr" rid="caffey.REF.schweiger.2003.547">Schweiger et al 2003</xref>].</p>
        </sec>
      </sec>
      <sec id="caffey.Resources">
        <title>Resources</title>
      </sec>
      <sec id="caffey.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="caffey.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The recurrence of the defining pathogenic variant in unrelated individuals suggests that this CpG dinucleotide is a mutational hot spot in <italic toggle="yes">COL1A1</italic> [<xref ref-type="bibr" rid="caffey.REF.tomso.2003.303">Tomso &#x00026; Bell 2003</xref>]. The pathogenic variant is predicted to introduce an arginine-to-cysteine substitution into the triple-helical domain of &#x003b1;1(I) chains of type I collagen [<xref ref-type="bibr" rid="caffey.REF.dalgleish.1997.181">Dalgleish 1997</xref>].</p>
          <p>Although the exact mechanism of pathogenesis is unknown, possibilities as to why this variant causes the Caffey disease phenotype include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>The variant may disrupt a site important for protein interaction since it is located in the carboxy-terminal cyanogen bromide terminus 6 (CB6) of the &#x003b1;1(I) chain, which has been shown to interact with both IL-2 and the amyloid protein precursor (APP) [<xref ref-type="bibr" rid="caffey.REF.somasundaram.2000.38170">Somasundaram et al 2000</xref>, <xref ref-type="bibr" rid="caffey.REF.di_lullo.2002.4223">Di Lullo et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>The p.Arg1014Cys substitution (also known as p.Arg836Cys) within the &#x003b1;1(I) chain reduces the thermal stability of the collagen triple helix [<xref ref-type="bibr" rid="caffey.REF.gensure.2005.1250">Gensure et al 2005</xref>].</p>
            </list-item>
          </list>
          <p><bold>Gene structure.</bold> The transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000088.3">NM_000088.3</ext-link> has 51 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="caffey" object-id="caffey.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic allelic variants.</bold>
<italic toggle="yes">COL1A1</italic> c.3040C&#x0003e;T is the defining pathogenic variant responsible for the Caffey disease phenotype. No other allelic variants are known to be responsible for this disease. The <italic toggle="yes">COL1A1</italic> database of allelic variants (initiated by <xref ref-type="bibr" rid="caffey.REF.dalgleish.1997.181">Dalgleish [1997]</xref>) describes <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://oi.gene.le.ac.uk/variants.php?select_db=COL1A1&#x00026;action=view&#x00026;view=0002156%2C0000261%2C21">this variant</ext-link>.</p>
          <table-wrap id="caffey.T.selected_col1a1_pathogenic_vari" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Selected <italic toggle="yes">COL1A1</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_caffey.T.selected_col1a1_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_caffey.T.selected_col1a1_pathogenic_vari_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_caffey.T.selected_col1a1_pathogenic_vari_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_caffey.T.selected_col1a1_pathogenic_vari_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3040C&#x0003e;T</td>
                  <td headers="hd_h_caffey.T.selected_col1a1_pathogenic_vari_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1014Cys<break/>(Arg836Cys)</td>
                  <td headers="hd_h_caffey.T.selected_col1a1_pathogenic_vari_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000088.3">NM_000088.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000079.2">NP_000079.2</ext-link>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="caffey.TF.2.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> Type I collagen has 1464 amino acid residues.</p>
          <p><bold>Abnormal gene product.</bold> The p.Arg1014Cys amino acid substitution (also known as p.Arg836Cys) changes the X position of Gly-X-Y repeating amino acid triplets of the &#x003b1;1(I) chain of type I collagen. In most collagenopathies, the pathogenesis of the disease is thought to be related to alterations in the glycine residues. Cysteine, on the other hand, is normally present in the amino and carboxyl propeptides of type I procollagen chains, but is removed during collagen processing [<xref ref-type="bibr" rid="caffey.REF.persikov.2000.14960">Persikov et al 2000</xref>].</p>
        </sec>
      </sec>
      <sec id="caffey.References">
        <title>References</title>
        <sec id="caffey.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="caffey.Literature_Cited.reflist0">
            <ref id="caffey.REF.al_kaissi.2009.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al Kaissi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petje</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeBrauwer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grill</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klaushofer</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Professional awareness is needed to distinguish between child physical abuse from other disorders that can mimic signs of abuse (Skull base sclerosis in infant manifesting features of infantile cortical hyperostosis): a case report and review of the literature.</article-title>
                <source>Cases J.</source>
                <volume>2</volume>
                <fpage>133</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19203363</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.behbehani.1997">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Behbehani</surname>
                    <given-names>EMH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Ramzi</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farhatulla</surname>
                    <given-names>MB</given-names>
                  </name>
                </person-group>
                <article-title>Caffey's disease: a case report.</article-title>
                <source>Dental News.</source>
                <year>1997</year>
              </element-citation>
            </ref>
            <ref id="caffey.REF.berthier.1988.443">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berthier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huret</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Caffey disease responding to high-dose immunoglobulin.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>147</volume>
                <fpage>443</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">3294018</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.bull.1974.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bull</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feingold</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1974</year>
                <article-title>Autosomal dominant inheritance of Caffey disease.</article-title>
                <source>Birth Defects Orig Artic Ser.</source>
                <volume>10</volume>
                <fpage>139</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">4609117</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.caffey.1957.347">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Caffey</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1957</year>
                <article-title>Infantile cortical hyperostosis; a review of the clinical and radiographic features.</article-title>
                <source>Proc R Soc Med.</source>
                <volume>50</volume>
                <fpage>347</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">13431894</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.caffey.1945.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Caffey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silverman</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>1945</year>
                <article-title>Infantile cortical hyperostosis. Preliminary report on a new syndrome.</article-title>
                <source>Am J Roentgenol Radium Ther Nucl Med.</source>
                <volume>54</volume>
                <fpage>1</fpage>
              </element-citation>
            </ref>
            <ref id="caffey.REF.cerrutimainardi.2011.1385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cerruti-Mainardi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venturi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spunton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favaron</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zignani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porvera</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dallapiccola</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Infantile cortical hyperostosis and COL1A1 mutation in four generations.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>170</volume>
                <fpage>1385</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">21567126</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.cho.2008.947">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moon</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>DY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>DY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoo</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>IH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The c.3040C&#x0003e;T mutation in COL1A1 is recurrent in Korean patients with infantile cortical hyperostosis (Caffey disease).</article-title>
                <source>J Hum Genet.</source>
                <volume>53</volume>
                <fpage>947</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18704262</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.dahlstrom.2001.521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dahlstrom</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arbuckle</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozlowski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peek</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynolds</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sillence</surname>
                    <given-names>DO</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Lethal prenatal onset infantile cortical hyperostosis (Caffey disease).</article-title>
                <source>Pathology.</source>
                <volume>33</volume>
                <fpage>521</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11827425</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.dalgleish.1997.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dalgleish</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>The human type I collagen mutation database.</article-title>
                <source>Nucleic Acids Res.</source>
                <volume>25</volume>
                <fpage>181</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9016532</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.de_almeida.2007.363">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Almeida</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hercowitz</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korkes</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troster</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Cortical hyperostosis secondary to prolonged use of prostaglandin E1.</article-title>
                <source>Clinics (Sao Paulo)</source>
                <volume>62</volume>
                <fpage>363</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17589681</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.de_jong.1995.134">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Jong</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Perinatal death in two sibs with infantile cortical hyperostosis (Caffey disease).</article-title>
                <source>Am J Med Genet.</source>
                <volume>59</volume>
                <fpage>134</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8588573</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.di_lullo.2002.4223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Lullo</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korkko</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ala-Kokko</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>San Antonio</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen.</article-title>
                <source>J Biol Chem.</source>
                <volume>277</volume>
                <fpage>4223</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11704682</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.drinkwater.1997.773">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drinkwater</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crino</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogburn</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hecht</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Recurrent severe infantile cortical hyperostosis (Caffey disease) in siblings.</article-title>
                <source>Prenat Diagn.</source>
                <volume>17</volume>
                <fpage>773</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9267903</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.fried.1981.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fried</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manor</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pajewski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starinsky</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vure</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>Autosomal dominant inheritance with incomplete penetrance of Caffey disease (infantile cortical hyperostosis).</article-title>
                <source>Clin Genet.</source>
                <volume>19</volume>
                <fpage>271</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">7023758</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.gensure.2005.1250">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gensure</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;kitie</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barclay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depalma</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bastepe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abuzahra</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couper</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sillence</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ala Kokko</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidman</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000fc;ppner</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders.</article-title>
                <source>J Clin Invest.</source>
                <volume>115</volume>
                <fpage>1250</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15864348</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.hall.2005">
              <mixed-citation publication-type="webpage">Hall C. Caffey disease. <italic toggle="yes">Orphanet Encyclopedia</italic>. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&#x00026;Expert=1310">online</ext-link>. 2005. Accessed 3-2-16.</mixed-citation>
            </ref>
            <ref id="caffey.REF.hasegawa.2004.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichiyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsubara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tokuda</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furukawa</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Caffey disease in a 6-month-old girl.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>163</volume>
                <fpage>175</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14735359</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.hochwald.2011.113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hochwald</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osiovich</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Prenatal Caffey disease.</article-title>
                <source>Isr Med Assoc J.</source>
                <volume>13</volume>
                <fpage>113</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">21443040</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.issa_el_khoury.2012.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Issa El Khoury</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kreichati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kharrat</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghanem</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Tumoral calcinosis of the cervical spine and its association with Caffey disease in a 4-month-old boy: case report and review of the literature.</article-title>
                <source>J Pediatr Orthop B.</source>
                <volume>21</volume>
                <fpage>286</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">22080299</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.kamoungoldrat.2008.2145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamoun-Goldrat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Infantile cortical hyperostosis (Caffey disease): a review.</article-title>
                <source>J Oral Maxillofac Surg.</source>
                <volume>66</volume>
                <fpage>2145</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">18848116</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.kamoungoldrat.2008.1820">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamoun-Goldrat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinovic</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saada</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sonigo-Cohen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Prenatal cortical hyperostosis with COL1A1 gene mutation.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>146A</volume>
                <fpage>1820</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18553566</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.katz.1981.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkpatrick</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papanicolaou</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desai</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>Case report 139. Infantile cortical hyperostosis (Caffey disease).</article-title>
                <source>Skeletal Radiol.</source>
                <volume>6</volume>
                <fpage>77</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">7008205</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.krishnamurthy.2012.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krishnamurthy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srinivasan</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Severe thrombocytosis as initial manifestation of Caffey disease in a 4 month old infant.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <volume>59</volume>
                <fpage>345</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22213629</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.lachman.2007">
              <mixed-citation publication-type="book">Lachman RS. <italic toggle="yes">Taybi and Lachman&#x02019;s Radiology of Syndromes, Metabolic Disorders and Skeletal Dysplasias.</italic> 5 ed. Philadelphia, PA: Mosby Elsevier; 2007.</mixed-citation>
            </ref>
            <ref id="caffey.REF.langer.1986.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Langer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Case report 363: Infantile cortical hyperostosis (Caffey disease ICH) iliac bones, femora, tibiae and left fibula.</article-title>
                <source>Skeletal Radiol.</source>
                <volume>15</volume>
                <fpage>377</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">3526563</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.l_colier.1992.637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000e9;colier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bercau</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzal&#x000e8;s</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afriat</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rambaud</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Kermadec</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Radiographic, haematological, and biochemical findings in a fetus with Caffey disease.</article-title>
                <source>Prenat Diagn.</source>
                <volume>12</volume>
                <fpage>637</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">1359527</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.lo.2010.397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lo</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lau</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>So</surname>
                    <given-names>KT</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Infantile cortical hyperostosis (Caffey disease): a possible misdiagnosis as physical abuse.</article-title>
                <source>Hong Kong Med J.</source>
                <volume>16</volume>
                <fpage>397</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20890006</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.malfait.2007.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Malfait</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Symoens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Backer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermanns-L&#x000ea;</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakalihasan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapi&#x000e8;re</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coucke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.</article-title>
                <source>Hum Mutat.</source>
                <volume>28</volume>
                <fpage>387</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">17211858</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.nemec.2012.e565">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nemec</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachman</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Radiological aspects of prenatal-onset cortical hyperostosis</article-title>
                <comment>[Caffey Dysplasia]</comment>
                <source>Eur J Radiol.</source>
                <volume>81</volume>
                <fpage>e565</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">21726971</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.newberg.1981.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newberg</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tampas</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>Familial infantile cortical hyperostosis: an update.</article-title>
                <source>AJR Am J Roentgenol.</source>
                <volume>137</volume>
                <fpage>93</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">6787897</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.nuytinck.2000.1398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nuytinck</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagae</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierard</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermanns-Le</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>66</volume>
                <fpage>1398</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">10739762</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.olauson.2008.929">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Olauson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krajisnik</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>TE</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphateaemia syndrome.</article-title>
                <source>Eur J Endocrinol</source>
                <volume>158</volume>
                <fpage>929</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">18322299</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.parnell.2010.s39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parnell</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parisi</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Caffey disease.</article-title>
                <source>Pediatr Radiol.</source>
                <volume>40</volume>
                <fpage>S39</fpage>
                <pub-id pub-id-type="pmid">20967539</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.persikov.2000.14960">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Persikov</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramshaw</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkpatrick</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodsky</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Amino acid propensities for the collagen triple-helix.</article-title>
                <source>Biochemistry.</source>
                <volume>39</volume>
                <fpage>14960</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11101312</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.ranganath.2011.877">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ranganath</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laine</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;kitie</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phadke</surname>
                    <given-names>SR</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>COL1A1 mutation in an Indian child with Caffey disease.</article-title>
                <source>Indian J Pediatr.</source>
                <volume>78</volume>
                <fpage>877</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21249479</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.restrepo.2004.454">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Restrepo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;nchez</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palacios</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Infantile cortical hyperostosis of the mandible.</article-title>
                <source>Ear Nose Throat J.</source>
                <volume>83</volume>
                <fpage>454</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15372912</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.savarirayan.2002.694">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Savarirayan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amor</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachman</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Prenatal cortical hyperostosis (Caffey disease).</article-title>
                <source>Pediatr Radiol.</source>
                <volume>32</volume>
                <fpage>694</fpage>
                <pub-id pub-id-type="pmid">12422848</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.schweiger.2003.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schweiger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaoui</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tennstedt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinschert</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Antenatal onset of cortical hyperostosis (Caffey disease): case report and review.</article-title>
                <source>Am J Med Genet A</source>
                <volume>120A</volume>
                <fpage>547</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">12884437</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.somasundaram.2000.38170">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Somasundaram</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruehl</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiling</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackermann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmid</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riecken</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuppan</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Collagens serve as an extracellular store of bioactive interleukin 2.</article-title>
                <source>J Biol Chem.</source>
                <volume>275</volume>
                <fpage>38170</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10982811</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.suphapeetiporn.2007.280">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suphapeetiporn</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tongkobpetch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahayosnond</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shotelersuk</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Expanding the phenotypic spectrum of Caffey disease.</article-title>
                <source>Clin Genet.</source>
                <volume>71</volume>
                <fpage>280</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17309652</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.tampas.1961.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tampas</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Buskirk</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>OS</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Soule</surname>
                    <given-names>AB</given-names>
                  </name>
                </person-group>
                <year>1961</year>
                <article-title>Infantile cortical hyperostosis.</article-title>
                <source>JAMA</source>
                <volume>175</volume>
                <fpage>491</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">13775121</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.thometz.1996.304">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thometz</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiRaimondo</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A case of recurrent Caffey&#x02019;s disease treated with naproxen.</article-title>
                <source>Clin Orthop Relat Res.</source>
                <issue>323</issue>
                <fpage>304</fpage>
                <pub-id pub-id-type="pmid">8625597</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.tomso.2003.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tomso</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Sequence context at human single nucleotide polymorphisms: overrepresentation of CpG dinucleotide at polymorphic sites and suppression of variation in CpG islands.</article-title>
                <source>J Mol Biol.</source>
                <volume>327</volume>
                <fpage>303</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12628237</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.wendling.2009.409">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wendling</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hafsaoui</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurain</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Runge</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magy-Bertrand</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prati</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Dysphagia and hypervitaminosis A: cervical hyperostosis.</article-title>
                <source>Joint Bone Spine.</source>
                <volume>76</volume>
                <fpage>409</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">19289294</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="caffey.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="caffey.Suggested_Reading.reflist0">
            <ref id="caffey.REF.glorieux.2005.1142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Glorieux</surname>
                    <given-names>FH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Caffey disease: an unlikely collagenopathy.</article-title>
                <source>J Clin Invest.</source>
                <volume>115</volume>
                <fpage>1142</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15864344</pub-id>
              </element-citation>
            </ref>
            <ref id="caffey.REF.van_buskirk.1961.613">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Buskirk</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tampas</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>OS</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>1961</year>
                <article-title>Infantile cortical hyperostosis; an inquiry into its familial aspects.</article-title>
                <source>Am J Roentgenol Radium Ther Nucl Med.</source>
                <volume>85</volume>
                <fpage>613</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">13779881</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="caffey.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="caffey.Author_Notes">
          <title>Author Notes</title>
          <p>Dr Guerin, Ms Dupuis, and Dr Mendoza are currently conducting a research study for individuals with a clinical or molecular diagnosis of Caffey disease. The goals of the study are to better describe the natural history, pathogenesis, and complications in order to enhance the management and counseling of Caffey disease.</p>
        </sec>
        <sec id="caffey.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>29 November 2012 (cd) Revision: prenatal testing available</p>
            </list-item>
            <list-item>
              <p>2 August 2012 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>17 February 2012 (ag) Initial submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="caffey.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Skeletal survey in a five-week-old female with the defining <italic toggle="yes">COL1A1</italic> p.Arg1014Cys pathogenic variant who presented with painful swelling over the right tibia. Notice widespread involvement with (a) symmetric bilateral periosteal reaction involving the mandible and clavicles; (b) asymmetric involvement of the humerus, proximal shaft of the radius, and distal shaft of the ulna; (c) and (d) tibia and fibula. Arrows point to significant subperiosteal thickening and bowing. Asymmetric reactions of the iliac bones, femurs, tibias, and left fibula were also noted (not shown). Symptoms resolved within a month of onset.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="caffey-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="caffey.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Clinical photograph and x-ray of two-month-old male with the defining <italic toggle="yes">COL1A1</italic> p.Arg1014Cys pathogenic variant who presented with irritability and swelling over the right tibia. The arrows denote the area of swelling on clinical examination and the subperiosteal reaction of the right tibia observed on x-ray. Skeletal survey at presentation also revealed bilateral involvement of the clavicles, radii, and ulnae. Clinical symptoms resolved within a month of onset and periosteal changes remodeled over a period of one year.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="caffey-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
